Survey: Digital health investments will rely on ROI and clinical validation in 2023

A GSR Ventures survey of 50 investors reveals return on investment and clinical validation would be vital to a company's success next year.

from MobiHealthNews https://ift.tt/1zbkRq6
https://ift.tt/ASOQthH

Post a Comment

Previous Post Next Post